The effect of prior exposure to imatinib on transplant-related mortality.
Michael W. Deininger(Versiti Blood Center of Wisconsin), Dietger Niederwieser(Leipzig University of Applied Sciences), Jesús Martı́nez(Hospital Universitari i Politècnic La Fe), Edgar Faber(University Hospital Olomouc), Brian Druker(Oregon Health & Science University), Nigel H. Russell(Guy's and St Thomas' NHS Foundation Trust), Andreas Hochhaus(Jena University Hospital), Eduardo Olavarría(Universidad de Navarra), Michael Kiehl(Klinikum Frankfurt Höchst), Gottfried Doelken(Universität Greifswald), H. Greinix(Medical University of Vienna), Thoralf Lange, Rainer Krahl, Thomas Fischer(University Hospital Magdeburg), Arnon Nagler(Sheba Medical Center), Urs Schanz(University Hospital of Zurich), Kerstin Schaefer(Nuremberg Hospital), Aloïs Gratwohl, Anna Sureda(Institut d'Investigació Biomédica de Bellvitge), Liisa Volin(Helsinki University Hospital), Richard T. Maziarz(Oregon Health & Science University), Simona Iacobelli(Universität Hamburg), Enrico Pogliani(Azienda Ospedaliera San Gerardo), C Boqué(Institut Català d'Oncologia), Axel A. Fauser, H. Kolb(National Cancer Institute), Ronald Brand(Universität Hamburg), Leo F. Verdonck(Isala), Herbert G. Sayer(Friedrich Schiller University Jena), Michael Schleuning(Deutsche Klinik für Diagnostik)
PubMed
April 1, 2006
Cited by 114
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms
|Leukemia|2022|3.8k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3.1k
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a <i>FLT3</i> Mutation
|New England Journal of Medicine|2017|2.2k